Has Abhilash Akinapelli, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,473 in general payments to Abhilash Akinapelli, MD across 430 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abhilash Akinapelli, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abhilash Akinapelli, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abhilash Akinapelli, MD

Interventional Cardiology · Reno, NVNPI 1467734285

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,111 of the $14,473 with a category attached, or 76.8%. 15 manufacturers reported payments, led by Abbott at 36.0% of the total.

$14,473in general payments, 2019–2025

Across 430 payments — averaging $33.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$5K
Edwards Lifesciences$3K
Boston Scientific$3K
Medtronic$1K
Abiomed$774
Biosense Webster, Inc.$532
plus $1K from 9 others

What the payments were for

Travel & lodging$3,36223%
Food & beverage$11,11177%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	77	$5,217
Edwards Lifesciences	78	$3,091
Boston Scientific	143	$2,621
Medtronic(2 entities)	42	$1,043
Abiomed	39	$774
Biosense Webster, Inc.	23	$532
Shockwave Medical, Inc	13	$404
Angiodynamics, Inc.	1	$187
Novo Nordisk	2	$140
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$134
E.r. Squibb & Sons, L.L.C.	2	$124
W. L. Gore & Associates, Inc.	2	$85
Merit Medical Systems Inc	1	$63
Chiesi USA, Inc.	2	$31
Kiniksa Pharmaceuticals International, PLC	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mitra Clip system$1,910
MitraClip$1,013
SAPIEN 3 Ultra RESILIA$556
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$312
AVVIGO Guidance System$262
AMPLATZER AMULET$261
Impella$234
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$225
WATCHMAN FLX$215
AngioVac$187
SYMPLICITY G3$147
CoreValve Evolut$129
WATCHMAN Access System$127
Edwards SAPIEN 3 Transcatheter Heart Valve$126
PASCAL$117
CAMZYOS$110
VIGILANT$108

How this compares

$14,473 in reported general payments places this provider in the 65th percentile of 62 interventional cardiology providers in Nevada.

See all interventional cardiology providers in Nevada →

Medicare billing

Part B allowed, 2024

$363,664

Medicare patients

2,096

Services billed

3,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	116	$122,486
EntrestoSacubitril/Valsartan	24	$30,670
XareltoRivaroxaban	28	$26,188
JardianceEmpagliflozin	33	$24,432
Amiodarone Hcl	58	$2,599
Atorvastatin Calcium	147	$2,398
Metoprolol Succinate	137	$2,252
ClopidogrelClopidogrel Bisulfate	88	$1,538
Losartan Potassium	83	$1,327
Rosuvastatin Calcium	66	$1,200
Furosemide	110	$740
Spironolactone	61	$671
Carvedilol	59	$636
Potassium Chloride	30	$584
Amlodipine Besylate	63	$513

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Reno

Lina Ya'qoubReno$30K
Bradley NelsonReno$13K
Jad Al DanafReno$10K
Benjamin EbnerReno$10K
Napatt KanjanahattakijReno$10K
Troy WiedenbeckReno$5K
Hideki IchinoReno$5K
Chanwit RoongsritongReno$3K
Robert SwackhamerReno$797
Michael NewmarkReno$323

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →